February 18, 2026 | HearFromHer, RareDisease
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical system often defaults to “normalizing” debilitating symptoms.

Listen to the full episode here.
In the latest episode of the Hear From Her podcast, Tatyana Kushner (Weill Cornell Medicine) and Andrea Goldstein (Mirum Pharmaceuticals), discuss why this status quo is dangerous. While ICP might present as “just an itch,” it is a complex condition where elevated bile acids can lead to severe risks for the infant, including respiratory distress or stillbirth.
The Data Behind the Disparities Recent research led by Dr. Kushner suggests a 70% recurrence rate for ICP in subsequent pregnancies. Furthermore, the data reveals significant racial disparities; for instance, while Primary Biliary Cholangitis (PBC) was long thought to be a condition primarily affecting Northern European women, it is now clear that women of color face significant barriers to diagnosis and access to care.
Listen to the full episode here.
The Future of Care: Genetics and Advocacy
As Andrea Goldstein puts it, “Every failure in a study leads to key learnings that help us be successful the next time.” For the modern clinician and patient alike, the goal is clear: don’t just learn the system—have the courage to change it. Listen to the full episode here.
Follow us for updates on upcoming podcasts and more insightful conversations.
For more information, please contact Jelena Spyropoulos.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Victoria Harvey-Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & Engagement Conference
Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago. These presentations reflect our commitment to advancing diabetes care…
Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of Excellence for Instructional Design—a central hub of expertise and strategic capability, dedicated to…
The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic…
Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 symposia.
The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power and value of CME. As pioneers in clinician education for…
Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer’s disease diagnosis. Read the full article here. The study, published in…
Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next…
Medscape Education is proud to announce the presentation of eight innovative educational research publications at the American Thoracic Society (ATS) 2025 International Conference, held May 16–21 in San Francisco, CA….
The future of CME is here—and it’s personal, powerful, and primed for impact. In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical…
